Skip to Content

Nobivac EDGE DAPPv

This page contains information on Nobivac EDGE DAPPv for veterinary use.
The information provided typically includes the following:
  • Nobivac EDGE DAPPv Indications
  • Warnings and cautions for Nobivac EDGE DAPPv
  • Direction and dosage information for Nobivac EDGE DAPPv

Nobivac EDGE DAPPv

This treatment applies to the following species:
Company: Intervet/Merck Animal Health

CANINE DISTEMPER-ADENOVIRUS TYPE 2-PARAINFLUENZA-PARVOVIRUS VACCINE

Modified Live Virus

FOR ANIMAL USE ONLY

IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.

THIMEROSAL FREE

Nobivac EDGE DAPPv Indications

This product has been shown to be effective for the vaccination of healthy dogs 6 weeks of age or older against canine distemper virus, canine adenovirus type 1 (hepatitis), canine parainfluenza virus and canine parvovirus. To review efficacy and safety data, go to productdata.aphis.usda.gov.

Data indicate the development of corneal opacity is not associated with the use of this product.

Dosage and Administration

Transfer contents of the sterile diluent vial to the Nobivac® EDGE™ DAPPv vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Inject one dose (0.5 mL) subcutaneously. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Precautions

● Store at 2° - 8°C.

● Do not freeze.

● Do not mix with other vaccines.

● Use new, non-chemically sterilized needles and syringes.

● Inactivate unused contents before disposal.

Warnings

● Contains gentamicin as a preservative.

● Vaccinate only healthy, non-parasitized dogs.

● Do not vaccinate pregnant bitches.

● The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

● The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN/PCN 165A/13D1.21

1 800 224-5318 (USA)

1 866 683-7838 (Canada)

For patent information:

http://www.merck.com/product/patent/home.html

 

Code

 

25x1 DOSE

153538

156159-01

CPN: 1047546.0

MERCK ANIMAL HEALTH
Intervet Inc.

2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service:   800-521-5767
Order Desk:   800-648-2118
Technical Service (Companion Animal):   800-224-5318
Technical Service (Livestock):   800-211-3573
Fax:   973-937-5557
Website:   www.merck-animal-health-usa.com
Every effort has been made to ensure the accuracy of the Nobivac EDGE DAPPv information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2019 Animalytix LLC. Updated: 2019-09-30

Hide